4.8 Article

Ultrastable Silver Nanoparticles for Rapid Serology Detection of Anti-SARS-CoV-2 Immunoglobulins G

期刊

ANALYTICAL CHEMISTRY
卷 94, 期 20, 页码 7383-7390

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c00870

关键词

-

资金

  1. Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA-FRS)
  2. Fonds de la Recherche Scientifique (FRS-FNRS)
  3. Actions de Recherches Concertees of the Federation Wallonie-Bruxelles
  4. Green Chemistry Program of Innoviris
  5. Fondation Jaumotte-Demoulin
  6. ULB
  7. Appel a projets Special COVID-19 - ULB

向作者/读者索取更多资源

A dipstick assay using silver nanoparticles stabilized by a thin calix[4]arene-based coating was developed for detecting Anti-SARS-CoV-2 IgG in clinical samples. Compared to traditional lateral-flow immunoassays using gold nanoparticles, this silver nanoparticle-based system showed a lower limit of detection and similar signals with a smaller number of particles. The dipstick assay demonstrated impressive results in real clinical samples, with 100% specificity for negative samples and a sensitivity of 73% for positive samples.
Dipstick assays using silver nanoparticles (AgNPs) stabilized by a thin calix[4]arene-based coating were developed and used for the detection of Anti-SARS-CoV-2 IgG in clinical samples. The calixarene-based coating enabled the covalent bioconjugation of the SARS-CoV-2 Spike Protein via the classical EDC/sulfo-NHS procedure. It further conferred remarkable stability to the resulting bioconjugated AgNPs, as no degradation was observed over several months. In comparison with lateral-flow immunoassays (LFIAs) based on classical gold nanoparticles, our AgNP-based system constitutes a clear step forward, as the limit of detection for Anti-SARS-CoV-2 IgG was reduced by 1 order of magnitude and similar signals were observed with 10 times fewer particles. In real clinical samples, the AgNP-based dipstick assays showed impressive results: 100% specificity was observed for negative samples, while a sensitivity of 73% was determined for positive samples. These values match the typical sensitivities obtained for reported LFIAs based on gold nanoparticles. These results (i) represent one of the first examples of the use of AgNP-based dipstick assays in the case of real clinical samples, (ii) demonstrate that ultrastable calixarene-coated AgNPs could advantageously replace AuNPs in LFIAs, and thus (iii) open new perspectives in the field of rapid diagnostic tests.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据